NCT05888441

Brief Summary

Falls are common among people with vision impairment and can lead to devastating health consequences. Understanding the functions of vision and how the visual characteristics of obstacles in the walking path impact the gait of people with vision impairment is necessary to create strategies to prevent falls in this population. The purpose of this study is to determine how adults with vision impairment change their gait behavior when stepping over obstacles that vary in height and contrast to the ground. We will then determine the mechanisms of gaze behavior that correlate to the gait behavior.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
33mo left

Started Apr 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress54%
Apr 2023Dec 2028

Study Start

First participant enrolled

April 14, 2023

Completed
20 days until next milestone

First Submitted

Initial submission to the registry

May 4, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 5, 2023

Completed
5.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2028

Last Updated

November 13, 2025

Status Verified

November 1, 2025

Enrollment Period

5.7 years

First QC Date

May 4, 2023

Last Update Submit

November 12, 2025

Conditions

Outcome Measures

Primary Outcomes (4)

  • Vertical foot clearance, lead limb

    Distance from lowest point of foot (heel or toe) to top of obstacle

    During a single intervention visit (Study Visit 2), up to 2-3 hours in duration.

  • Foot placement variability

    Standard deviation of position of toe to obstacle over 2-4 steps before the obstacle

    During a single intervention visit (Study Visit 2), up to 2-3 hours in duration.

  • Obstacle crossing speed

    Speed from lead toe off immediately before the obstacle to trail heel down immediately after the obstacle.

    During a single intervention visit (Study Visit 2), up to 2-3 hours in duration.

  • Gaze sequencing

    Sequence of fixations from start of trial to end of trial, normalized to the total duration and divided into 100 equal segments

    During a single intervention visit (Study Visit 2), up to 2-3 hours in duration.

Study Arms (2)

Low Vision Group

EXPERIMENTAL

At a single study visit, the group of low vision participants will be asked to perform a series of short walking trials. During each trial they will walk at a self-selected speed along a walkway (6 meters in length) that may or may not contain an obstacle to step over. The trials will be randomly varied with regard to an obstacle's presence, height, and contrast from the walkway surface. Repeated trials of each condition variation will be performed during the visit.

Other: Obstacle characteristics

Control Group

ACTIVE COMPARATOR

At a single study visit, the group of age-matched participants without low vision will be asked to perform a series of short walking trials. During each trial they will walk at a self-selected speed along a walkway (6 meters in length) that may or may not contain an obstacle to step over. The trials will be randomly varied with regard to an obstacle's presence, height, and contrast from the walkway surface. Repeated trials of each condition variation will be performed during the visit.

Other: Obstacle characteristics

Interventions

In the walking trials, when an obstacle is present, the obstacle height and obstacle contrast level will be varied across the trial repetitions. Each participant will be exposed to obstacles of two heights: the first will be 1 centimeter in height, and the second will be approximately 20% of the subject's leg length (ranging in physical height between 15 - 22 centimeters to cover a range of leg lengths in the population). Obstacles (of both heights) will also be painted such that their measured luminance (or contrast) level against the floor luminance is varied. High contrast obstacles will have ≥80% Michelson contrast and low contrast obstacles will have ≤30% Michelson contrast.

Control GroupLow Vision Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 or over
  • Able to walk independently
  • Either have normal vision, or impaired vision.
  • Impaired vision is defined as binocular visual acuity of 20/25 or worse with or without a central scotoma; and/or binocular visual field that is restricted to an average of 100 degrees in diameter or less
  • Control subjects will have visual acuity of 20/40 or better.

You may not qualify if:

  • Not cleared by a medical provider for moderate physical activity
  • Self-report or have a history of: vestibular disorder or deafness
  • Medical history of any condition that affects the ability to walk for up to 2 hours with breaks, such as feeling dizzy or faint, chest pain, palpitations, pain or numbness in the legs, shortness of breath,
  • Cognitive limitations either by self-report or a score on the Mini Mental State Exam below 24 (out of 30)
  • Walking or gait abnormalities, such as those caused from an injury, surgery, severe arthritis, or neurological condition such as Parkinson's disease
  • Unable to walk without any walking aids such as a walker, cane, guide dog, or oxygen tank.
  • Does not speak English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Indiana University

Bloomington, Indiana, 47405, United States

RECRUITING

MeSH Terms

Conditions

Vision, Low

Condition Hierarchy (Ancestors)

Vision DisordersSensation DisordersNeurologic ManifestationsNervous System DiseasesEye DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Kierstyn A Napier-Dovorany, OD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

May 4, 2023

First Posted

June 5, 2023

Study Start

April 14, 2023

Primary Completion (Estimated)

December 31, 2028

Study Completion (Estimated)

December 31, 2028

Last Updated

November 13, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Locations